Do truncated cyclins contribute to aberrant cyclin expression in cancer?

Cell Cycle

Volumn 5, Issue 5, 2006, Pages 472-477

  Van Dross, Rukiyah ^a   Browning, Philip J ^b   Pelling, Jill C ^c  

^a EAST CAROLINA UNIVERSITY   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alternative splicing; Carcinogenesis; Cyclin; Prognosis; Truncated cyclins

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN D; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; CYCLINE; VIRUS PROTEIN;

CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN HERPESVIRUS 8; HYPERACTIVITY; MOLECULAR WEIGHT; NONHUMAN; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; RNA SPLICING; VIRUS DNA CELL DNA INTERACTION; WILD TYPE;

HUMAN HERPESVIRUS 8;

EID: 33644755629     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.5.2516     Document Type: Review

References (63)

1. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 1994; 14:2066-76.
2. 1 in mammalian fibroblasts. Science 1993; 259:1908-12.
3. Girard F, Strausfeld U, Fernandez A, Lamb NJ. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 1991; 67:1169-79.
4. Desdouets C, Sobczak-Thepot J, Murphy M, Brechot C. Cyclin A: Function and expression during cell proliferation. Prog Cell Cycle Res 1995; 1:115-23.
5. Doree M, Galas S. The cyclin-dependent protein kinases and the control of cell division. FASEB J 1994; 8:1114-21.
6. Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature 1999; 401:297-300.
7. 1 progression in NIH 3T3 cells. Mol Cell Biol 1995; 15:3654-63.
8. Bortner DM, Rosenberg MP. Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis. Cell Growth Differ 1995; 6:1579-89.
9. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54:1812-17.
10. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 1995; 11:1005-11.
11. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Knudsen ES. Cyclin D1 splice variants: Differential effects on localization, Rb phosphorylation, and cellular transformation. J Biol Chem 2003; 278:30339-47.
12. Lu F, Gladden AB, Diehl JA. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 2003; 63:7056-61.
13. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998; 12:3499-11.
14. Diehl JA, Zindy F, Sherr CJ. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 1997; 11:957-72.
15. Alt JR, Cleveland JL, Hannink M, Diehl JA. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 2000; 14:3102-14.
16. Holley SL, Heighway J, Hoban PR. Induced expression of human CCND1 alternative transcripts in mouse Cyl-1 knockout fibroblasts highlights functional differences. Int J Cancer 2005; 114:364-70.
17. Izzo JG, Papadimitrakopoulou VA, Liu DD, den Hollander PLC, Babenko IM, Keck J, El Naggar AK, Shin DM, Lee JJ, Hong WK, Hittelman WN. Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer. J Natl Cancer Inst 2003; 95:198-05.
18. Kong S, Amos CI, Luthra R, Lynch PM, Levin B, Frazier ML. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res 2000; 60:249-52.
19. Zheng Y, Shen H, Sturgis EM, Wang LE, Eicher SA, Strom SS, Frazier ML, Spitz MR, Wei Q. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: A case-control study. Carcinogenesis 2001; 22:1195-99.
20. Pakakasama S, Chen TT, Frawley W, Muller CY, Douglass EC, Lee R, Pollock BH, Tomlinson GE. CCND1 polymorphism and age of onset of hepatoblastoma. Oncogene 2004; 23:4789-92.
21. Howe D, Lynas C. The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241. Haematologica 2001; 86:563-69.
22. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FE, Aldam DM, Denton AS. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346:799-02.
23. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332:1186-91.
24. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-69.
25. Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, Chang Y, Knowles DM. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 1996; 70:8218-23.
26. Davis MA, Sturzl MA, Blasig C, Schreier A, Guo HG, Reitz M, Opalenik SR, Browning PJ. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 1997; 89:1868-74.
27. Reed JA, Nador RG, Spaulding D, Tani Y, Cesarman E, Knowles DM. Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system. Blood 1998; 91:3825-32.
28. Carbone A, Gloghini A, Bontempo D, Monini P, Tirelli U, Volpe R, Browning PJ, Gaidano G. Proliferation in HHV-8-positive primary effusion lymphomas is associated with expression of HHV-8 cyclin but independent of p27(kip1). Am J Pathol 2000; 156:1209-15.
29. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, Ganem D. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 1998; 72:8309-15.
30. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, Haase AT. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997; 71:715-19.
31. Verschuren EW, Hodgson JG, Gray JW, Kogan S, Jones N, Evan GI. The role of p53 in suppression of KSHV cyclin-induced lymphomagenesis. Cancer Res 2004; 64:581-89.
32. Verschuren EW, Klefstrom J, Evan GI, Jones, N. The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2002; 2:229-41.
33. Godden-Kent D, Talbot SJ, Boshoff C, Chang Y, Moore P, Weiss RA, Mittnacht S. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol 1997; 71:4193-98.
34. Verschuren EW, Jones N, Evan GI. The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin. J Gen Virol 2004; 85:1347-61.
35. Van Dross R, Yao S, Asad S, Westlake G, Mays DJ, Barquero L, Duell S, Pietenpol JA, Browning PJ. Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells. J Natl Cancer Inst 2005; 97:656-66.
36. Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N. Herpes viral cyclin/cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 1997; 390:184-187.
37. Child ES, Mann DJ. Novel properties of the cyclin encoded by human herpesvirus 8 that facilitate exit from quiescence. Oncogene 2001; 20:3311-22.
38. Welcker M, Lukas J, Strauss M, Bartek J. Enhanced protein stability: A novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells. Oncogene 1996; 13:419-25.
39. Russell A, Thompson MA, Hendley J, Trute L, Armes J, Germain D. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer. Oncogene 1999; 18:1983-91.
40. Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P, Rosen N. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 1994; 9:1925-29.
41. Delmer A, Ajchenbaum-Cymbalista F, Tang R, Ramond S, Faussat AM, Marie JP, Zittoun R. Overexpression of cyclin D2 in chronic B-cell malignancies. Blood 1995; 85:2870-76.
42. Schmidt BA, Rose A, Steinhoff C, Strohmeyer T, Hartmann M, Ackermann R. Upregulation of cyclin-dependent kinase 4/cyclin D2 expression but downregulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors. Cancer Res 2001; 61:4214-21.
43. Faussillon M, Monnier L, Junien C, Jeanpierre C. Frequent overexpression of cyclin D2/cyclin-dependent kinase 4 in Wilms' tumor. Cancer Lett 2005; 221:67-75.
44. Henegariu O, Vance GH, Heiber D, Pera M, Heerema NA. Triple-color FISH analysis of 12p amplification in testicular germ-cell tumors using 12p band-specific painting probes. J Mol Med 1998; 76:648-55.
45. Denicourt C, Kozak CA, Rassart E. Gris1, a new common integration site in Graffi Murine Leukemia Virus-induced leukemias: Overexpression of a truncated cyclin D2 due to alternative splicing. J Virol 2003; 77:37-44.
46. Donnellan R, Chetty R. Cyclin E in human cancers. FASEB J 1999; 13:773-80.
47. Porter DC, Zhang N, Danes C, McGahren MJ, Harwell RM, Faruki S, Keyomarsi K. Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms. Mol Cell Biol 2001; 21:6254-69.
48. Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002; 347:1566-75.
49. Harwell RM, Porter DC, Danes C, Keyomarsi K. Processing of cyclin E differs between normal and tumor breast cells. Cancer Res 2000; 60:481-89.
50. Akli S, Keyomarsi K. Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy. Cancer Biol Ther 2003; 2:S38-S47.
51. Akli S, Zheng PJ, Multani AS, Wingate HF, Pathak S, Zhang N, Tucker SL, Chang S, Keyomarsi K. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res 2004; 64:3198-08.
52. Bales E, Mills L, Milam N, McGahren-Murray M, Bandyopadhyay D, Chen D, Reed JA, Timchenko N, van den Oord JJ, Bar-Eli M, Keyomarsi K, Medrano EE. The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo. Cancer Res 2005; 65:692-97.
53. Bedrosian I, Lu KH, Verschraegen C, Keyomarsi K. Cyclin E deregulation alters the biologic properties of ovarian cancer cells. Oncogene 2004; 23:2648-57.
54. Wang J, Chenivesse X, Henglein B, Brechot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 1990; 343:555-57.
55. Berasain C, Patil D, Perara E, Huang SM, Mouly H, Brechot C. Oncogenic activation of a human cyclin A2 targeted to the endoplasmic reticulum upon hepatitis B virus genome insertion. Oncogene 1998; 16:1277-88.
56. Anger M, Bryja V, Jirmanova L, Hampl A, Carrington M, Motlik J, Dvorak P, Kubelka M. The appearance of truncated cyclin A2 correlates with differentiation of mouse embryonic stem cells. Biochem and Biophys Res Commun 2003; 302:825-30.
57. Welm AL, Timchenko NA, Ono Y, Sorimachi H, Radomska HS, Tenen DG, Lekstrom-Himes J, Darlington GJ. C/EBPalpha is required for proteolytic cleavage of cyclin A by calpain 3 in myeloid precursor cells. J Biol Chem 2002; 277:33848-56.
58. Lozano JC, Schatt P, Marques F, Peaucellier G, Fort P, Feral JP, Geneviere AM, Picard A. A presumptive developmental role for a sea urchin cyclin B splice variant. J Cell Biol 1998; 140:283-93.
59. Offner N, Derancourt J, Lozano JC, Schatt P, Picard A, Peaucellier G. Cybip, a starfish cyclin B-binding protein, is involved in meiotic M-phase exit. Biochem Biophys Res Commun 2003; 300:121-27.
60. Li H, Lahti JM, Valentine M, Saito M, Reed SI, Look AT, Kidd VJ. Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: Deletion of the CCNC gene in human tumors. Genomics 1996; 32:253-59.
61. Loyer P, Trembley JH, Katona R, Kidd VJ, Lahti JM. Role of cdk/cyclin complexes in transcription and RNA splicing. Cellular Signalling 2005; 17:1033-51.
62. Li H, Lahti JM, Kidd VJ. Alternatively spliced cyclin C mRNA is widely expressed, cell cycle regulated, and encodes a truncated cyclin box. Oncogene 1996; 13:705-12.
63. Leclerc V, Tassan JP, O'Farrell PH, Nigg EA, Leopold P. Drosophila cdk8, a kinase partner of cyclin C that interacts with the large subunit of RNA polymerase II. Mol Biol Cell 1996; 7:505-13.